Adjunctive Safinamide Increases On Time in Parkinson

Share

(December 28, 2016) – Based on a recent clinical trial, researchers at the University College London Institute of Neurology have concluded that safinamide is a safe and effective adjunct to levodopa in patients with PD and motor fluctuations. Read more

Click for a printer friendly version

Back to top